This analysis examines the market position and future outlook for Genzyme. The profile encompasses global and US specific company strategy, portfolio and pipeline analysis and assessment of financial performance, with US, rest of world and global forecasts for key drugs to 2010. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information
Reasons to Purchase
Identify the key products that will drive Genzyme’s double-digit growth through to 2010
Benchmark Genzyme’s performance against key rivals in the ethical pharmaceutical and biotechnology sector
